Pipeline – Isarna Therapeutics
Pipeline Isarna has established a broad portfolio of next-generation first- and best-in-class antisense oligonucleotides blocking three key TGF-β variants with therapeutic potential across …
Isarna Therapeutics – Leading Expertise in TGF-ß Biology and …
Pipeline Isarna has a pipeline of different antisense molecules blocking the production of TGF-Beta
isarna-therapeutics.com
isarna-therapeutics.com
Isarna Therapeutics is focused on developing a pipeline of next-generation oligonucleotides that target the various isoforms of transforming growth factor beta (TGF-β), a family of proteins …
News & Events – Isarna Therapeutics
Events & Conferences Meet us at: Due to the current COVID-19 situation and its profound impact on scientific, investor and business development conferences worldwide, Isarna will update its …
The Company – Isarna Therapeutics
Claus is a serial entrepreneur in the Life Sciences with 20 years expertise in the Industry. He co-founded Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) in 2001 and was CFO up to the listing …
We have then developed a rich pipeline of novel potent LNA-modified antisense oligodeoxynucleotide gapmers designed from the various TGF-b isoform mRNA sequences in …